The methodology to capture the full economic value of vaccinations is still a work in progress

The methodology to capture the full economic value of vaccinations is still a work in progress

More than half of all purchased doses did NOT end up in arms. Preparing for a pandemic is difficult: so far, 42% of the purchased doses...

...and influence attitudes!

After too cheap - comes no supply!

public-private partnerships with the same goals and supplementary missions The network to prevent & fight infectious disease outbreaks is...

...in "times of peace"? Here is some food for thought without trying to compare! It's a tough question to answer and in both cases a...

For the endemic phase: apply the learning of the pandemic: keep seamless monitoring systems & governance systems in place to react timely...

Natural immunisation played a role, but Covid-19 vaccines were the game-changer: reducing severity of disease and lowering the death rate...

...and monitoring standards must be global as well to be prepared for all eventualities

Continue to monitor Covid in 2023 to be able to respond quickly and adequately to all eventualities

Thank you to all those we collaborated with in 2022. We look forward to seeing you all in 2023!

...and innovation drives vaccine usage

Out of 16 billion doses of vaccines used in 2021, 10.7 billion doses were Covid 19 vaccinations.

Get your 4th dose NOW if eligible!

Get your 4th dose NOW if eligible!